SCHEMBL29916260

SCHEMBL29916260

Cc1cc(C)c(Oc2nc(CCc3ccccc3)ccc2C(=O)NS(=O)(=O)c2cccc(N)n2)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 3/20 0.39
ITGAV P06756 3/20 0.39
ITGA2B P08514 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
EGFR P00533 1/20 0.34
NOS1 P29475 2/20 0.33
NOS2 P35228 2/20 0.33
PLA2G2A P14555 1/20 0.33
SCN9A Q15858 2/20 0.33
FLT1 P17948 1/20 0.32
FLT4 P35916 1/20 0.32
KDR P35968 1/20 0.32
NOS3 P29474 1/20 0.32
NR3C1 P04150 1/20 0.32
MMP1 P03956 2/20 0.32
MMP9 P14780 2/20 0.32
MMP13 P45452 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17647992 1.00 ITGB3 (0.39) ITGB3ITGAVITGA2BL3MBTL1NPC1
SCHEMBL17649314 0.92 KLKB1 (0.36) ITGB3ITGAVITGA2BEGFRSCN9A
SCHEMBL29916533 0.92 KLKB1 (0.36) ITGB3ITGAVITGA2BEGFRSCN9A
SCHEMBL29916998 0.89 FLT1 (0.35) ITGB3ITGAVITGA2BEGFRSCN9A
SCHEMBL17648601 0.89 FLT1 (0.35) ITGB3ITGAVITGA2BEGFRSCN9A
SCHEMBL29917902 0.88 ITGB3 (0.37) ITGB3ITGAVITGA2BEGFRSCN9A
SCHEMBL29916262 0.88 ITGB3 (0.37) ITGB3ITGAVITGA2BEGFRNOS2
SCHEMBL17648682 0.88 ITGB3 (0.37) ITGB3ITGAVITGA2BEGFRSCN9A
SCHEMBL17647642 0.88 ITGB3 (0.37) ITGB3ITGAVITGA2BEGFRNOS2
SCHEMBL19439818 0.88 GLO1 (0.41) L3MBTL1NPC1RAB9ASMN1; SMN2MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3798214-B1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2022-09-14 EP claimed